IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase
Status:
Terminated
Trial end date:
2020-04-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how Humulin-R regular insulin affects the body's
ability to feel low blood sugar (hypoglycemia) when delivered intranasally compared to
placebo in subjects with Type 1 Diabetes (T1D) with hypoglycemia awareness. The study will
use continuous glucose monitoring (CGM) to collect this information. The study drug or
placebo will be administered using an intranasal device.
Phase:
Phase 2
Details
Lead Sponsor:
HealthPartners Institute
Collaborators:
International Diabetes Center at Park Nicollet Juvenile Diabetes Research Foundation